José Alberto García

ORCID: 0000-0002-1203-7260
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • COVID-19 Clinical Research Studies
  • Long-Term Effects of COVID-19
  • SARS-CoV-2 and COVID-19 Research
  • HIV/AIDS Research and Interventions
  • HIV/AIDS drug development and treatment
  • HIV-related health complications and treatments
  • Systemic Lupus Erythematosus Research
  • SARS-CoV-2 detection and testing
  • HIV Research and Treatment
  • Systemic Sclerosis and Related Diseases
  • Rheumatoid Arthritis Research and Therapies
  • Fibroblast Growth Factor Research
  • Viral-associated cancers and disorders
  • Bone health and osteoporosis research
  • Injury Epidemiology and Prevention
  • Lymphoma Diagnosis and Treatment
  • Sports injuries and prevention
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Respiratory viral infections research
  • Biosensors and Analytical Detection
  • Advanced biosensing and bioanalysis techniques
  • Polyomavirus and related diseases
  • Chronic Lymphocytic Leukemia Research
  • Immunodeficiency and Autoimmune Disorders
  • Shoulder Injury and Treatment

Florida International University
2024-2025

Emory University
2025

Universitat de Miguel Hernández d'Elx
2003-2024

Hospital General Universitario de Elche
2003-2024

Instituto de Salud Carlos III
2021-2024

Centro de Investigación Biomédica en Red
2022-2024

Hospital Clínico San Carlos
2023

Hospital Vega Baja
2023

Instituto de Investigación Sanitaria del Hospital Clínico San Carlos
2023

Hospital Universitario Infanta Sofía
2020-2022

From 1958 to 1970, >100,000 people in northern Chile were exposed a well-documented, distinct period of high drinking water arsenic concentrations. We previously reported ecological evidence suggesting that early-life exposure this population resulted increased mortality adults from several outcomes, including lung and bladder cancer.

10.1158/1055-9965.epi-14-0059 article EN Cancer Epidemiology Biomarkers & Prevention 2014-05-24

BackgroundThe virological and immunological effects of the immunomodulatory drugs used for COVID-19 remain unknown. We evaluated impact interleukin (IL)-6 blockade with tocilizumab on SARS-CoV-2 viral kinetics antibody response in patients COVID-19.MethodsProspective cohort study admitted COVID-19. Serial nasopharyngeal plasma samples were measured RNA S-IgG/N-IgG titers, respectively.Findings138 confirmed infection included; 76 (55%) underwent IL-6 blockade. Median initial SOFA (p = 0•016)...

10.1016/j.ebiom.2020.102999 article EN cc-by-nc-nd EBioMedicine 2020-09-16

The interdependencies of viral replication and the host immune response in patients with coronavirus disease 2019 (COVID-19) remain to be defined. We investigated determinants antibody response, predictors nonseroconversion, role antibodies on dynamics.This was a prospective study hospitalized COVID-19 that microbiologically confirmed by real-time polymerase chain reaction (RT-PCR). Serial nasopharyngeal oropharyngeal swabs plasma samples were obtained for measuring severe acute respiratory...

10.1093/ofid/ofab005 article EN cc-by-nc-nd Open Forum Infectious Diseases 2021-01-05

Background The pathophysiology of long-COVID remains unknown, and information is particularly limited for symptoms very long duration. We aimed to assess the serological, T-cell immune responses ANA titers patients with long-COVID-19 syndrome 1-year Methods Prospective, longitudinal study hospitalized COVID-19 followed-up 12 months. Sequential blood samples symptom questionnaires (CSQ) were obtained, humoral cellular responses, antinuclear antibodies (ANA) inflammation biomarkers analyzed....

10.3389/fimmu.2022.920627 article EN cc-by Frontiers in Immunology 2022-08-24

BackgroundWhether interleukin-6 (IL-6) blockade in patients with COVID-19 will affect the protective immunity against SARS-CoV-2 has become an important concern for anti-IL-6 therapy. We aimed to investigate effects of IL-6 on long-term SARS-CoV-2.MethodsProspective, longitudinal cohort study conducted hospitalized severe or critical laboratory confirmed infection. assessed humoral (anti-S1 domain spike [S], anti-nucleocapsid [N], anti-trimeric [TrimericS] IgG, and neutralizing antibodies...

10.1016/j.ebiom.2022.104153 article EN cc-by-nc-nd EBioMedicine 2022-07-08
Inés Suárez‐García Belén Alejos Víctoria Hernando Laura Viñuela Mar Vera and 95 more David Rial‐Crestelo Marı́a Jesús Pérez-Elı́as Helena Iglesias Joaquim Peraire Juan Tiraboschi Asunción Díaz Santiago Moreno Inmaculada Jarrín Santiago Moreno Inmaculada Jarrín David Dalmau Marta Navarro Maria Gonzalez Féderico García Eva Poveda José Antonio Iribarren Félix Gutiérrez Rafael Rubio Francesc Vidal Juan Berenguer Juan González María Ángeles Muñoz‐Fernández Inmaculada Jarrín Cristina Moreno Marta Rava Rebeca Izquierdo Jorge del Romero Raposo Cristina Marco Julián Puente María Ángeles Muñoz‐Fernández Elba Mauleón Roxana Juárez Joaquín Portilla Irene Portilla Esperanza Merino Gema García Iván Agea José Sánchez‐Payá Juan Carlos Rodrı́guez Livia Giner Sergio Reus Vicente Boix Diego Torrús Verónica Álvarez Julia Portilla María Remedios Alemán Valls Jehovana Hernández Ana López Lirola Dácil García Felícitas Díaz-Flores M. Mar Alonso Ricardo Pelazas Víctor Asensi M Eugenia Rivas Tomás Suárez‐Zarracina Eulalia Valle-Garay Javier Arias-Dı́az Federico Pulido Rafael Rubio Otilia Bisbal M. Asunción Hernando David Rial María Lagarde Octavio Arce Adriana Pinto Laura Muñoz Bermejo Mireia Santacreu Roser Navarro Candela Gonzalez José Antonio Iribarren María José Aramburu Xabier Camino Miguel Ángel von Wichmann Miguel Ángel Goenaga Ma Jesús Bustinduy Harkaitz Azkune Maialen Ibarguren Xabier Kortajarena Ignacio Álvarez-Rodriguez Leire Gil Lourdes Martínez Félix Gutiérrez Mar Masiá Catalina Robledano Sergio Padilla Javier García Abellán Paula Mascarell Araceli Adsuar Rafael J. Pascual Mar Carvajal Marta Fernández José Alberto García Ángela Botella Alba de la Rica Carolina Ding

Abstract Objectives To assess the effectiveness and tolerability of dolutegravir (DTG)/lamivudine (3TC) among treatment-naive virologically suppressed treatment-experienced individuals in multicentre cohort Spanish HIV/AIDS Research Network (CoRIS) during years 2018–2021. Methods We used multivariable regression models to compare viral suppression (VS) [HIV RNA load (VL) <50 copies/mL] change CD4 cell counts at 24 48 (±12) weeks after initiation with dolutegravir/lamivudine or other...

10.1093/jac/dkad102 article EN cc-by-nc Journal of Antimicrobial Chemotherapy 2023-04-26

This prospective study aimed to determine the prevalence of long COVID in patients hospitalized for SARS-CoV-2 infection from March 2020 July 2022 and assess impact different viral lineages. A total 2,524 were followed up 12 months, with persistent symptoms reported 35.2% at one month, decreasing thereafter. Omicron variant initially showed higher symptom intensity, but this trend diminished over time. Certain lineages, notably Delta lineages AY.126 AY.43, sublineages BA.1.17, BA.2.56,...

10.1016/j.isci.2024.109536 article EN cc-by-nc-nd iScience 2024-03-19

Abstract Excessive interleukin-6 signaling is a key factor contributing to the cytokine release syndrome implicated in clinical manifestations of COVID-19. Preliminary results suggest that tocilizumab, humanized monoclonal anti-interleukin-6 receptor antibody, may be beneficial severely ill patients, but no data are available on earlier stages disease. An anticipated blockade might hypothetically prevent catastrophic consequences overt storm. We evaluated early-given tocilizumab patients...

10.1038/s41598-020-74001-3 article EN cc-by Scientific Reports 2020-10-08

We evaluated a standardized interferon-γ (IFN-γ) release assay (IGRA) for detection of T-cell immune response after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection or vaccination.This prospective study included patients with disease 2019 (COVID-19) different severity illness and follow-up (FU), vaccinated subjects, healthy unvaccinated persons. SARS-CoV-2 was measured using specific quantitative IGRA in whole blood (Euroimmun, Germany) TrimericS-IgG neutralizing...

10.1093/cid/ciab1021 article EN Clinical Infectious Diseases 2021-12-09
Javier Martínez‐Sanz Jorge Díaz-Álvarez Marta Rosas Cancio-Suárez Raquel Ron José Antonio Iribarren and 95 more Enrique Bernal Félix Gutiérrez Andrés Ruiz Sancho Noemí Cabello Julián Olalla Santiago Moreno Sergio Serrano‐Villar Inmaculada Jarrín David Dalmau Ma Luisa Masó Navarro Maria Gonzalez Féderico García Eva Poveda José Antonio Iribarren Félix Gutiérrez Rafael Rubio Francesc Vidal Juan Berenguer Juan González María Ángeles Muñoz‐Fernández Inmaculada Jarrín Cristina Moreno Marta Rava Rebeca Izquierdo María Ángeles Muñoz‐Fernández Elba Mauleón Joaquín Portilla Irene Portilla Esperanza Merino Gema García Iván Agea José Sánchez‐Payá Juan Carlos Rodrı́guez Livia Giner Sergio Reus Vicente Boix Diego Torrús Verónica Pérez Julia Portilla Juan Luís Gómez Jehovana Hernández Ana López Lirola Dácil García Felícitas Díaz-Flores M. Mar Alonso Ricardo Pelazas María Remedios Alemán Valls Víctor Asensi María Eugenia Rivas Carmenado Tomás Suárez‐Zarracina Federico Pulido Rafael Rubio Otilia Bisbal M. Asunción Hernando David Rial María Lagarde Octavio Arce Adriana Pinto Laura Muñoz Bermejo Mireia Santacreu Roser Navarro Candela Gonzalez José Antonio Iribarren María José Aramburu Xabier Camino Miguel Ángel von Wichmann Miguel Ángel Goenaga Ma Jesús Bustinduy Harkaitz Azkune Maialen Ibarguren Xabier Kortajarena Ignacio Álvarez-Rodriguez Leire Gil Lourdes Martínez Félix Gutiérrez Catalina Robledano Mar Masiá Sergio Padilla Araceli Adsuar Rafael J. Pascual Marta Fernández Antonio Galiana José Alberto García Xavier Barber Vanessa Agullo Javier García Abellán Reyes Pascual Guillermo Telenti Lucia Guillén Ángela Botella Roberto Muga Arantza Sanvisens Daniel Fuster Juan Berenguer Isabel Gutiérrez

BackgroundWhile a low CD4/CD8 ratio during HIV treatment correlates with immunosenescence, its value in identifying patients at an increased risk for clinical events remains unclear.MethodsWe analyzed data from the CoRIS cohort to determine whether CD4 count, CD8 and year two of antiretroviral therapy (ART) could predict serious non-AIDS (SNAEs) next five years. These included major adverse cardiovascular events, non-AIDS-defining malignancies, non-accidental deaths. We used pooled logistic...

10.1016/j.ebiom.2023.104773 article EN cc-by EBioMedicine 2023-08-26

Chlamydia trachomatis-lymphogranuloma venereum (LGV) is a sexually transmitted infection (STI) and an uncommon cause of proctitis rectal mass. When the rectum affected, patients may experience symptoms such as bleeding, pain, tenesmus, which can resemble or proctocolitis be mistaken for malignancy. We present case 40-year-old male patient with well-controlled HIV, who initially exhibited imaging findings concerning neoplasia. Following colonoscopy biopsy swab polymerase chain reaction (PCR),...

10.7759/cureus.78516 article EN Cureus 2025-02-04

Data on the performance of saliva specimens for diagnosing coronavirus disease 2019 (COVID-19) in ambulatory patients are scarce and inconsistent. We assessed saliva-based detecting severe acute respiratory syndrome 2 (SARS-CoV-2) by reverse transcriptase PCR (RT-PCR) community setting compared three different collection methods. This prospective study was conducted primary care centers. RT-PCR performed paired nasopharyngeal swabs (NPS) samples collected from outpatients with a broad...

10.1128/jcm.03033-20 article EN Journal of Clinical Microbiology 2021-01-11

To assess the benefits of remdesivir in hospitalized COVID-19 patients receiving combined immunomodulatory therapy (CIT) with dexamethasone and tocilizumab.This was a cohort study microbiologically confirmed patients. The primary outcome all-cause 28 day mortality. Secondary outcomes were need for invasive mechanical ventilation (IMV) IMV/death. Subgroup analyses according to SARS-CoV-2 cycle threshold (Ct) values inflammation biomarkers performed. Multivariable marginal structural Cox...

10.1093/jac/dkac144 article EN Journal of Antimicrobial Chemotherapy 2022-04-21

The aim of this study was to determine the association playing style and efficacy variables with football success in a professional league. Match statistics were obtained from 23 teams competing 2017-2018 2018-2019 seasons Spanish national league(LaLiga). Offensive defensive calculated. Pearson's correlation coefficient tests principal component analysis (PCA) applied establish influence these on number points at end season ranking position. In isolation, completion showed highest A...

10.1080/02640414.2021.1976488 article EN Journal of Sports Sciences 2021-09-09
Coming Soon ...